Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart

Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

2021 IMPACT FACTOR 4.402

Call for Papers - Special Section on Quantitative Systems Pharmacology for June 2023

Call for Papers - Special Section on Clinical Pharmacology for August 2023

  • Emily Stevenson
  • Elevated ANGPT1 Protects Diabetic Nephropathy
  • Pegylated UCN1 Improves Autoimmune Disease
  • Cholesterol Esterification and Acute Lung Injury
  • ENBT1-Mediated 6-Mercaptopurine Uptake by Leukemia Cells
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Fast Forward Articles

  • You have access
    Activation of GPR183 by 7α,25-dihydroxycholesterol induces behavioral hypersensitivity through MAPK and NF-κB
    Kathryn Braden, Michela Campolo, Ying Li, Zhoumou Chen, Timothy M. Doyle, Luigino Antonio Giancotti, Emanuela Esposito, Jinsong Zhang, Salvatore Cuzzocrea, Christopher Kent Arnatt and Daniela Salvemini
    Journal of Pharmacology and Experimental Therapeutics September 18, 2022, JPET-AR-2022-001283; DOI: https://doi.org/10.1124/jpet.122.001283
  • You have access
    Metabotropic glutamate receptors modulate exocytotic tau release and propagation
    Francesca Mazzo, Ioana Butnaru, Olivera Grubisha, Elena Ficulle, Helen Sanger, Griffin Fitzgerald, Feng Pan, Francesca Pasqui, Tracey Murray, James Monn, Xia Li, Michael Hutton, Suchira Bose, Giampietro Schiavo and Emanuele Sher
    Journal of Pharmacology and Experimental Therapeutics September 18, 2022, JPET-AR-2022-001307; DOI: https://doi.org/10.1124/jpet.122.001307
  • You have access
    Botulinum toxin A, a better choice for skeletal muscle block in a comparative study with lidocaine in rats
    Ke Xu, Zhan Zhang, Yueying Li, Lili Song, Jin Gou, Chengkuan Sun, Jiayang Li, Shuang Du, Rangjuan Cao and Shusen Cui
    Journal of Pharmacology and Experimental Therapeutics September 18, 2022, JPET-AR-2022-001313; DOI: https://doi.org/10.1124/jpet.122.001313
  • You have access
    Differential Activation and Desensitization States Promoted by Non-canonical α7 nAChR Agonists
    Clare Stokes, Gisela Andrea Camacho-Hernandez, Ganesh A. Thakur, Xiaoxuan Wu, Palmer Taylor and Roger L. Papke
    Journal of Pharmacology and Experimental Therapeutics September 2, 2022, JPET-AR-2022-001354; DOI: https://doi.org/10.1124/jpet.122.001354
  • You have access
    Regulation of Ferroptosis by non-coding RNAs: Mechanistic insights
    Ammad Ahmad Farooqi, Gulnara Kapanova, Sundetgali Kalmakhanov, Abay Z. Kussainov and Zaure Datkhayeva
    Journal of Pharmacology and Experimental Therapeutics September 2, 2022, JPET-MR-2022-001225; DOI: https://doi.org/10.1124/jpet.121.001225
  • You have access
    Is diminazene an angiotensin-converting enzyme 2 (ACE2) activator? Experimental evidence and implications
    Shiva Hadi Esfahani, Srinidhi Jayaraman and Vardan T. Karamyan
    Journal of Pharmacology and Experimental Therapeutics September 2, 2022, JPET-AR-2022-001339; DOI: https://doi.org/10.1124/jpet.122.001339
View more published ahead of print articles

About Journal of Pharmacology and Experimental Therapeutics

A leading research journal in the field of pharmacology, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology. 

Current issue

Journal of Pharmacology and Experimental Therapeutics: 383 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 383, Issue 1
1 Oct 2022
  • Table of Contents
  • About the Cover
  • Index by author

JPET is published continuously. Articles are added as they are ready and assigned to monthly issues. Check this site for new content or sign up for content alerts.

TOP 10 REASONS TO SUBMIT TO JPET:

  1. Free ASPET member submission & reduced page charges.
  2. Free color figures.
  3. Free accepted paper PDF access.
  4. Opportunity to Highlight trainee authors.
  5. Showcase important & interesting articles each month.
  6. Timely proofs and listing in PubMed.
  7. Transfer option to any ASPET journal.
  8. A goal to initiate Podcasts for top accepted articles.
  9. A goal of 20 days submission to 1st decision - GOAL MET.
  10. A goal of 9 days from acceptance to publication. - GOAL MET.

EDITOR'S CHOICE ARTICLES FOR September 2022:

  • Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese Mice
  • Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein - open access
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Nose-to-Brain Delivery
  • Iclepertin (BI 425809) in Schizophrenia-Related Models
  • Direct AMPK Activation for X-Linked Adrenoleukodystrophy
More...
Advertisement
For an alternate route to this Journal use this URL: http://intl-jpet.aspetjournals.org
Back to top
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics